IQInvest research note
12 OCT 2026 · 08:49 ET
VRTX
Vertex Pharmaceuticals Incorporated
$510.08
$6.83 (+1.36%)up 1.36%
12 October 2026 · delayed 15+ min
C
Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.
Vertex Pharmaceuticals Incorporated earns a C on excellent profit margins (>20%) and strong ROE (>20%) but high debt-to-equity ratio (>2.0) and MACD bearish (negative histogram). Reasonable investment with moderate upside potential.
Adjusted for Moderate investors, Medium-term investors 6.0% suggested allocation Change these
IQ-VRTX-20261012engine v1 · 7-category weighted scorecard